Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
Clinical trial NCT04792502 · RECRUITING
Trial details
- NCT number
- NCT04792502
- Sponsor
- Brown University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2027-08-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.